| Authors: |
Naleway AL; Kaiser Permanente Northwest, Center for Health Research, Portland, OR, United States., Ball S; Abt Associates, Inc, Cambridge, MA, United States., Kwong JC; ICES, Toronto, ON, Canada., Wyant BE; Abt Associates, Inc, Cambridge, MA, United States., Katz MA; Chief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel., Regan AK; School of Public Health, Curtin University, Perth, Australia., Russell ML; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Klein NP; Kaiser Permanente Vaccine Study Center, Oakland, CA, United States., Chung H; ICES, Toronto, ON, Canada., Simmonds KA; Alberta Health, Edmonton, AB, Canada., Azziz-Baumgartner E; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States., Feldman BS; Chief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel., Levy A; PathWest Laboratory Medicine Western Australia, Perth, Australia., Fell DB; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Drews SJ; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada., Garg S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States., Effler P; Western Australia Department of Health, Perth, Australia., Barda N; Chief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel., Irving SA; Kaiser Permanente Northwest, Center for Health Research, Portland, OR, United States., Shifflett P; Abt Associates, Inc, Cambridge, MA, United States., Jackson ML; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States., Thompson MG; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States. |
